JD

Jean-Marc Le Doussal

OP Ogd2 Pharma: 6 patents #1 of 8Top 15%
UN Universite De Nantes: 3 patents #24 of 365Top 7%
IM Immunotech: 2 patents #4 of 34Top 15%
NU Nantes Universite: 1 patents #9 of 41Top 25%
IL Institut De Cancerologie De L'Ouest: 1 patents #6 of 15Top 40%
CN CNRS: 1 patents #3,857 of 11,908Top 35%
Overall (All Time): #495,866 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11697689 Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs Stephane Birkle, Julien FLEURENCE, Sébastien FARAJ, Denis Cochonneau, Mickaël TERME +1 more 2023-07-11
11440968 Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2) Mickaël TERME, Mylene Dorvillius, Brigitte Assouline 2022-09-13
10745489 Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer Stephane Birkle, Denis Cochonneau, Mylene Dorvillius, Mickaël TERME 2020-08-18
10669328 Human IgG1 derived antibody with pro-apoptotic activity Mylene Dorvillius, Mickaël TERME 2020-06-02
10611848 Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity Mickaël TERME, Mylene Dorvillius 2020-04-07
10149812 Cosmetic composition comprising a muconopeptide Reto Stocklin, Louis Lamy, Bethsabee Coutaz 2018-12-11
10000575 Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer Stephane Birkle, Denis Cochonneau, Mylene Dorvillius, Mickaël TERME 2018-06-19
9566227 Cosmetic composition comprising a muconopeptide Reto Stocklin, Louis Lamy, Bethsabee Coutaz 2017-02-14
5274076 Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents Jacques Barbet, Michel Delaage, Anne Gruaz-Guyon 1993-12-28
5256395 Affinity enhancement immunological reagents for in vivo detection and killing of specific target cells Jacques Barbet, Michel Delaage 1993-10-26